Hedge Fund - Tontine Asset Management
Avadel Pharmaceuticals Plc (AVDL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $0 | 0% | 0 | $16.30 |
| 2 | 2024 - Q1 (2024-03-31) | $96,410,113 | 3.72% | 5,708,118 | $14.89 |
| 3 | 2023 - Q4 (2023-12-31) | $79,288,742 | 4.31% | 5,615,350 | $11.75 |
| 4 | 2023 - Q3 (2023-09-30) | $57,838,105 | 3.28% | 5,615,350 | $13.39 |
| 5 | 2023 - Q2 (2023-06-30) | $88,927,069 | 6.89% | 5,396,060 | $13.00 |
| 6 | 2023 - Q1 (2023-03-31) | $48,565,532 | 4.54% | 5,301,914 | $8.22 |
| 7 | 2022 - Q4 (2022-12-31) | $36,663,532 | 3.24% | 5,120,605 | $7.01 |
| 8 | 2022 - Q3 (2022-09-30) | $23,979,000 | 3.14% | 4,786,327 | $5.50 |
| 9 | 2022 - Q2 (2022-06-30) | $10,391,000 | 1.24% | 4,258,696 | $4.11 |
| 10 | 2022 - Q1 (2022-03-31) | $19,380,000 | 1.4% | 2,837,431 | $6.87 |
| 11 | 2021 - Q4 (2021-12-31) | $19,766,000 | 1.6% | 2,446,299 | $9.14 |
| 12 | 2021 - Q3 (2021-09-30) | $20,176,000 | 1.73% | 2,058,770 | $7.87 |
| 13 | 2021 - Q2 (2021-06-30) | $13,703,000 | 1.21% | 2,036,114 | $7.94 |
| 14 | 2021 - Q1 (2021-03-31) | $17,482,000 | 1.86% | 1,933,837 | $8.09 |
| 15 | 2020 - Q4 (2020-12-31) | $11,231,000 | 1.51% | 1,681,391 | $6.25 |
| 16 | 2020 - Q3 (2020-09-30) | $5,621,000 | 1.18% | 1,115,211 | $7.28 |
| 17 | 2020 - Q2 (2020-06-30) | $8,418,000 | 2.14% | 1,041,838 | $8.82 |
| 18 | 2020 - Q1 (2020-03-31) | $4,395,000 | 1.34% | 553,516 | $7.68 |
| 19 | 2019 - Q4 (2019-12-31) | $8,658,000 | 1.11% | 1,146,764 | $5.28 |
| 20 | 2019 - Q3 (2019-09-30) | $1,538,000 | 0.21% | 369,726 | $2.50 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center